Enrollment is complete for the randomized part of ENHANCE, a large clinical trial testing a new dosing schedule for Briumvi (ublituximab-xiiy) in adults with relapsing forms of multiple sclerosis (MS), […] The post ENHANCE trial testing simplified Briumvi dosing now fully enrolled appeared first on Multiple Sclerosis News Today.| Multiple Sclerosis News Today – The Web's Daily Resource for Multiple Scler...